Considering the synergistic impact of dyslipidemia and TREM-1 on the peripheral immune compartment, we in turn assessed the potential impact of HFCD feeding on TREM-1 surface expression by peripheral blood myeloid cell subsets. The gene discussed is TREM1; the disease is metabolic syndrome.